Association Between Smoking and SARS-CoV-2 Infection: Cross-sectional Study of the EPICOVID19 Internet-Based Survey

Abstract

Background Several studies have reported a low prevalence of current smoking among hospitalized COVID-19 cases; however, no definitive conclusions can be drawn. Objective We investigated the association of tobacco smoke exposure with nasopharyngeal swab (NPS) test results for SARS-CoV-2 infection and disease severity accounting for possible confounders. Methods The nationwide, self-administered, cross-sectional web-based Italian National Epidemiological Survey on COVID-19 (EPICOVID19) was administered to an Italian population of 198,822 adult volunteers who filled in an online questionnaire between April 13 and June 2, 2020. For this study, we analyzed 6857 individuals with known NPS test results. The associations of smoking status and the dose-response relationship with a positive NPS test result and infection severity were calculated as odds ratios (ORs) with 95% CIs by means of logistic and multinomial regression models adjusting for sociodemographic, clinical, and behavioral characteristics. Results Out of the 6857 individuals (mean age 47.9 years, SD 14.1; 4516/6857, 65.9% female), 63.2% (4334/6857) had never smoked, 21.3% (1463/6857) were former smokers, and 15.5% (1060/6857) were current smokers. Compared to nonsmokers, current smokers were younger, were more educated, were less affected by chronic diseases, reported COVID-19–like symptoms less frequently, were less frequently hospitalized, and less frequently tested positive for COVID-19. In multivariate analysis, current smokers had almost half the odds of a positive NPS test result (OR 0.54, 95% CI 0.45-0.65) compared to nonsmokers. We also found a dose-dependent relationship with tobacco smoke: mild smokers (adjusted OR [aOR] 0.76, 95% CI 0.55-1.05), moderate smokers (aOR 0.56, 95% CI 0.42-0.73), and heavy smokers (aOR 0.38, 95% CI 0.27-0.53). This inverse association also persisted when considering the severity of the infection. Current smokers had a statistically significantly lower probability of having asymptomatic (aOR 0.50, 95% CI 0.27-0.92), mild (aOR 0.65, 95% CI 0.53-0.81), and severe infections (aOR 0.27, 95% CI 0.17-0.42) compared to those who never smoked. Conclusions Current smoking was negatively associated with SARS-CoV-2 infection with a dose-dependent relationship. Ad hoc experimental studies are needed to elucidate the mechanisms underlying this association. Trial Registration ClinicalTrials.gov NCT04471701; https://clinicaltrials.gov/ct2/show/NCT04471701

Accessibility to SARS-CoV-2 swab test during the Covid-19 pandemic: Did age make the difference?

“…Of the total 38 items composing the questionnaire, some were developed ad-hoc for the purposes of the study, and some others were derived from validated scales in order to guarantee the harmonization and comparability of our data with that of other studies. Details on the questionnaire's content have been previously described [ 20 , 21 ]. Overall, the areas covered were the following: sociodemographic data, clinical status, personal characteristics and health status, housing conditions, lifestyle and behaviors during the lockdown.…”

Fear and Attitude towards SARS-CoV-2 (COVID-19) Infection in Spanish Population during the Period of Confinement

“…This self-administered, cross-sectional survey was used at national level to determine, among other aspects, fear of COVID-19. Furthermore, its items correspond to a large extent to those elaborated in our design, being the tool used in other different studies [ 52 , 53 , 54 , 55 ].…”

Associations between COVID-19 risk perceptions and smoking and quitting behavior among U.S. adults

“…While cigarette smoking is well-documented as the leading cause of preventable death ( Lariscy, 2019 ), scientists are now investigating the link between smoking and COVID-19 susceptibility and severity. Studies have found that smokers infected with COVID-19 may be more likely to become severely ill than those who do not smoke ( Berlin et al, 2020 , Heydari and Arfaeinia, 2021 , Patanavanich and Glantz, 2020 , Reddy et al, 2021 , Zhang et al, 2021 , Zhao et al, 2020 ) but it remains controversial whether smoking affects susceptibility to COVID-19 infection ( Heydari and Arfaeinia, 2021 , Prinelli et al, 2021 , Simons et al, 2020 , van Westen-Lagerweij et al, 2021 ). To promote public health, it is crucial to understand how COVID-19 impacts smokers and what factors may increase or decrease smoking behavior during the pandemic.…”